arginine-glycine-aspartate-o-methyltyrosine amide has been researched along with arginyl-glycyl-aspartic acid in 2 studies
Studies (arginine-glycine-aspartate-o-methyltyrosine amide) | Trials (arginine-glycine-aspartate-o-methyltyrosine amide) | Recent Studies (post-2010) (arginine-glycine-aspartate-o-methyltyrosine amide) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
---|---|---|---|---|---|
9 | 0 | 3 | 4,556 | 17 | 1,799 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gorczynski, RJ; King, LW; Miyano, M; Nicholson, NS; Panzer-Knodle, SG; Salyers, AK; Taite, BB; Tjoeng, FS; Williams, MH; Zupec, ME | 1 |
Grönman, M; Heinonen, T; Huttala, O; Knuuti, J; Li, XG; Moisio, O; Roivainen, A; Saraste, A; Toimela, T | 1 |
2 other study(ies) available for arginine-glycine-aspartate-o-methyltyrosine amide and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
Topics: Animals; Collagen; Dogs; Fibrinogen; Humans; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Thrombocytopenia | 1991 |
Association between [
Topics: Acetates; Angiogenesis Inducing Agents; Cell Culture Techniques, Three Dimensional; Cell Line, Tumor; Endothelial Cells; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Isotope Labeling; Models, Biological; Neovascularization, Physiologic; Oligopeptides; Tissue Distribution | 2021 |